Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
120.69
+4.58 (3.94%)
Feb 21, 2025, 4:00 PM EST - Market closed
Neurocrine Biosciences Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$168.35
Upside
+39.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $185 | Strong Buy | Reiterates | $185 | +53.29% | Feb 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $165 → $163 | Strong Buy | Maintains | $165 → $163 | +35.06% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $190 → $185 | Strong Buy | Maintains | $190 → $185 | +53.29% | Feb 10, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $154 → $148 | Hold | Maintains | $154 → $148 | +22.63% | Feb 7, 2025 |
| Wedbush | Wedbush | Buy Maintains $157 → $147 | Buy | Maintains | $157 → $147 | +21.80% | Feb 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $172 → $163 | Strong Buy | Maintains | $172 → $163 | +35.06% | Feb 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $190 → $185 | Strong Buy | Maintains | $190 → $185 | +53.29% | Feb 7, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $184 → $179 | Strong Buy | Maintains | $184 → $179 | +48.31% | Feb 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $170 → $185 | Buy | Maintains | $170 → $185 | +53.29% | Feb 4, 2025 |
| UBS | UBS | Strong Buy Maintains $162 → $176 | Strong Buy | Maintains | $162 → $176 | +45.83% | Jan 30, 2025 |
| UBS | UBS | Strong Buy Maintains $142 → $162 | Strong Buy | Maintains | $142 → $162 | +34.23% | Jan 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $160 | Buy | Reiterates | $160 | +32.57% | Dec 23, 2024 |
| Barclays | Barclays | Buy Maintains $160 → $165 | Buy | Maintains | $160 → $165 | +36.71% | Dec 23, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| Wedbush | Wedbush | Buy Reiterates $148 | Buy | Reiterates | $148 | +22.63% | Dec 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.